Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Suppression of tumorigenicity and metastasis in murine UV-2237 fibrosarcoma cells by infection with a retroviral vector harboring the interferon-beta gene

     In this study, we endeavored to determine the effectiveness of interferon β (IFNβ) gene therapy against highly metastatic murine UV-2237m fibrosarcoma cells. UV-2237m cells were engineered to produce murine I...

    Z. Dong, Shin-Hun Juang, Rakesh Kumar, Ines Eue in Cancer Immunology, Immunotherapy (1998)

  2. No Access

    Article

    Expression of theJE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells

    The purpose of this study was to determine whether the expression of theJE/MCP-1 gene encoding for the monocyte chemottractant protein, MCP-1 (also known as monocyte chemotactic and activating factor MCAF, TDCF, ...

    Suyun Huang, Rakesh K. Singh, in Cancer Immunology, Immunotherapy (1994)

  3. No Access

    Article

    The immunogenic properties of drug-resistant murine tumor cells do not correlate with expression of the MDR phenotype

    Alterations in the immunogenic properties of tumor cells frequently accompany selection for multipledrug-resistant (MDR) variants. Therefore, studies were performed to examine the hypothesis that overexpressio...

    Jerald J. Killion, Robert Radinsky, Zhongyun Dong in Cancer Immunology, Immunotherapy (1993)

  4. No Access

    Article

    Frozen-thawed human blood monocytes respond reproducibly to activation stimuli: Implications for screening of BRMs

    The purpose of this study was to identify the optimal freezing conditions for human blood monocytes to allow their recovery and use forin vitro screening of activation stimuli. Human monocytes separated from buff...

    Teruhiro Utsugi, Dale Brown, Akihiko Nii, Isaiah J. Fidler in Biotherapy (1992)

  5. No Access

    Article

    Unique histological changes in lung metastases of osteosarcoma patients following therapy with liposomal muramyl tripeptide (CGP 19835A lipid)

    We have recently begun a phase II trial in patients with osteosarcoma who developed pulmonary metastases during adjuvant chemotherapy or who presented with pulmonary metastases that persisted despite chemother...

    Eugenie S. Kleinerman, Austin K. Raymond in Cancer Immunology, Immunotherapy (1992)

  6. No Access

    Article

    In situ activation of mouse macrophages and therapy of spontaneous renal cell cancer metastasis by liposomes containing the lipopeptide CGP 31362

    We determined whether the intravenous administration of multilamellar vesicle liposomes (MLV) containing a lipopeptide analogue of a fragment from the cell wall of gram-negative bacteria (CGP 31 362) can rende...

    Teruhiro Utsugi, Colin P. N. Dinney, Jerald J. Killion in Cancer Immunology, Immunotherapy (1991)

  7. No Access

    Article

    Comparative efficacy of liposomes containing synthetic bacterial cell wall analogues for tumoricidal activation of monocytes and macrophages

    We examined the activation to the tumoricidal state of normal mouse peritoneal exudate macrophages, bone marrow macrophages, and human blood monocytes by liposomes containing either lipophilic muramyl tripepti...

    Teruhiro Utsugi, Akihiko Nii, Dominic Fan in Cancer Immunology, Immunotherapy (1991)

  8. No Access

    Article

    Liposomal delivery of biological response modifiers to macrophages

    Macrophages activated to the tumoricidal state can recognize and destroy neoplastic cells and leave normal cells unharmed. Systemic activation of macrophages can be achieved by the intravenous administration o...

    Charles C. Pak, Isaiah J. Fidler in Biotherapy (1991)

  9. No Access

    Article

    In vitro activation of tumoricidal properties in mouse macrophages using the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine (FMLP) incorporated in liposomes

    We investigated the ability of free or liposome-incorporated synthetic chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine (FMLP) to generate tumoricidal properties in mouse macrophages. As FMLP contains ...

    Kiyoshi Morikawa, Rajiv Nayar, Isaiah J. Fidler in Cancer Immunology, Immunotherapy (1988)

  10. No Access

    Article

    Destruction of tumor cells by monokines released from activated human blood monocytes: evidence for parallel and additive effects of IL-1 and TNF

    The incubation of human peripheral blood monocytes with endotoxins activates the cells to lyse tumorigenic targets directly and also induces the production and release into the culture medium of factors that p...

    Yukito Ichinose, Jerry Y. Tsao, Isaiah J. Fidler in Cancer Immunology, Immunotherapy (1988)

  11. No Access

    Article

    Antigenicity of UV radiation-induced murine tumors correlates positively with the level of adenosine deaminase activity

    The specific activities of adenosine deaminase (ADA) in 16 murine tumor cell lines derived from seven UV light-induced neoplasms (melanoma and fibrosarcoma) were determined. In each case, the specific activity...

    Sharon Lea Aukerman, Isaiah J. Fidler in Cancer Immunology, Immunotherapy (1987)

  12. No Access

    Article

    A microassay for the rapid and selective binding of cells from solid tumors to mouse macrophages

    A microassay was developed to study the rapid binding characteristics of murine macrophages activated by gamma interferon and muramyl dipeptide to adherent neoplastic or nonneoplastic target cells. The binding...

    Ikuo Saiki, Rajiv Nayar, Corazon Bucana in Cancer Immunology, Immunotherapy (1986)

  13. No Access

    Article

    Optimization and limitations of systemic treatment of murine melanoma metastases with liposomes containing muramyl tripeptide phosphatidylethanolamine

    The purpose of these studies was to determine the optimal conditions and limitations for the eradication of spontaneous melanoma metastases by the systemic administration of liposomes containing MTP-PE. Mice w...

    Isaiah J. Fidler in Cancer Immunology, Immunotherapy (1986)

  14. No Access

    Article

    Potentiation of direct antitumor cytotoxicity and production of tumor cytolytic factors in human blood monocytes by human recombinant interferon-gamma and muramyl dipeptide derivatives

    We investigated whether human peripheral blood monocytes isolated by centrifugal elutriation from healthy donors could be acitivated to become tumoricidal and release tumor cytolytic factor (TCF) subsequent to...

    Saburo Sone, Gabriel Lopez-Berestein, Isaiah J. Fidler in Cancer Immunology, Immunotherapy (1986)

  15. No Access

    Article

    The systemic activation of macrophages by liposomes containing immunomodulators

    The demonstration that appropriately activated macrophages can destroy microorganisms and cancer cells has prompted an intense search to identify agents which can render these cells active in vivo. Several nat...

    Rajiv Nayar, Isaiah J. Fidler in Springer Seminars in Immunopathology (1985)

  16. No Access

    Article

    Human lymphokine preparations which generate tumoricidal properties of human monocytes in vitro may be distinct from gamma interferon

    The purpose of these studies was to determine whether stimulated human lymphocytes produce lymphokines distinct from IFNγ, that can activate human blood monocytes to lyse tumor cells. We undertook this investi...

    Eugenie S. Kleinerman, Robert H. Wiltrout, Randy Zicht in Cancer Immunology, Immunotherapy (1985)

  17. No Access

    Article

    Efficient activation of human blood monocytes to a tumoricidal state by liposomes containing human recombinant gamma interferon

    Human recombinant gamma interferon (INF-γ) activated human peripheral blood monocytes to a cytotoxic state capable of lysing adherent tumorigenic cells without harming normal cells. The efficiency of INF-γ act...

    Wayne C. Koff, William E. Fogler, Jordan Gutterman in Cancer Immunology, Immunotherapy (1985)

  18. No Access

    Article

    The in situ activation of cytotoxic properties in murine Kupffer cells by the systemic administration of whole Mycobacterium bovis organisms or muramyl tripeptide

    We determined whether the systemic administration of viable Mycobacterium bovis organisms (BCG) or a lipophilic derivative of muramyl tripeptide (MTP-PE) would lead to the activation of antitumor properties in...

    Zuliang Xu, Isaiah J. Fidler in Cancer Immunology, Immunotherapy (1984)

  19. No Access

    Article

    Syngeneic humoral immune responses to tumor-associated antigens expressed by K-1735 UV-induced melanoma and its metastases

    An enzyme-linked immunoassay (ELISA) was developed to study syngeneic humoral immune response to a primary tumor and its metastases in the K-1735 ultraviolet light (UV)-induced C3H murine melanoma system. Bind...

    Patricia Thistlethwaithe, Darrell D. Davidson in Cancer Immunology, Immunotherapy (1983)

  20. No Access

    Article

    Systemic activation of macrophages by liposome-entrapped muramyl tripeptide in mice pretreated with the chemotherapeutic agent adriamycin

    The purpose of these studies was to determine whether macrophages of mice pretreated with the chemotherapeutic agent adriamycin (ADR) could be systemically activated by IV injection of liposomes containing mur...

    Goro Hisano, Isaiah J. Fidler in Cancer Immunology, Immunotherapy (1982)

previous disabled Page of 2